Knockdown of TLR4 gene in MDA-MB-231 resulted in a dramatic reduction of breast cancer cell viability and inhibition of IL-6 and IL-8 cytokines compared with vector control [41]. The gene discussed is TLR4; the disease is breast carcinoma.